Rhumbline Advisers Has $19.91 Million Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Rhumbline Advisers increased its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 38.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 513,546 shares of the company's stock after acquiring an additional 142,753 shares during the period. Rhumbline Advisers owned approximately 0.24% of Bath & Body Works worth $19,910,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in BBWI. Vontobel Holding Ltd. lifted its stake in shares of Bath & Body Works by 24.5% in the third quarter. Vontobel Holding Ltd. now owns 6,494 shares of the company's stock worth $207,000 after acquiring an additional 1,279 shares in the last quarter. Blue Trust Inc. increased its holdings in Bath & Body Works by 54.0% during the 3rd quarter. Blue Trust Inc. now owns 4,262 shares of the company's stock worth $136,000 after purchasing an additional 1,495 shares during the last quarter. Raymond James & Associates boosted its stake in shares of Bath & Body Works by 6.8% during the 3rd quarter. Raymond James & Associates now owns 89,680 shares of the company's stock valued at $2,863,000 after buying an additional 5,706 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Bath & Body Works by 14.9% during the third quarter. Sequoia Financial Advisors LLC now owns 6,514 shares of the company's stock worth $208,000 after buying an additional 847 shares in the last quarter. Finally, Impact Partnership Wealth LLC acquired a new stake in shares of Bath & Body Works during the third quarter worth approximately $365,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Down 4.5 %

Bath & Body Works stock traded down $1.84 during trading hours on Friday, hitting $38.51. 5,441,380 shares of the company traded hands, compared to its average volume of 3,304,652. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a market cap of $8.34 billion, a P/E ratio of 9.39, a P/E/G ratio of 0.95 and a beta of 1.83. The firm's 50-day simple moving average is $37.70 and its two-hundred day simple moving average is $33.81.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the business earned $0.48 earnings per share. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.08%. Bath & Body Works's dividend payout ratio is currently 19.51%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Barclays boosted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. raised Bath & Body Works from a "neutral" rating to an "overweight" rating and boosted their price objective for the company from $41.00 to $47.00 in a report on Tuesday. Wells Fargo & Company raised Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Morgan Stanley lowered their price target on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a report on Thursday, November 21st. Finally, Telsey Advisory Group restated an "outperform" rating and set a $43.00 price objective on shares of Bath & Body Works in a research note on Thursday. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $43.63.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.